What clinical laboratories need to know about the July 31 reporting deadline and the critical role market data plays in determining future Medicare rates.
The Protecting Access to Medicare Act (PAMA) reporting deadline is quickly approaching. Applicable laboratories have until Friday, July 31, 2026, to submit required private payer data to the Centers for Medicare & Medicaid Services (CMS) through the CMS Enterprise Portal.
While Congress delayed additional Clinical Laboratory Fee Schedule (CLFS) payment reductions until January 1, 2027, it did not postpone the current PAMA reporting requirements. Medicare rate setting under PAMA remains scheduled to move forward, and the data submitted during this reporting cycle will help inform future CLFS reimbursement rates. As more laboratories contribute data—including newly applicable hospital outreach laboratories—accurate and complete reporting is critical to ensuring future Medicare payment rates reflect the current laboratory market.
Applicable laboratories should act now to validate private payer data, confirm CMS Enterprise Portal access, and complete their submissions. Missing the deadline—or submitting incomplete or inaccurate information—may result in civil monetary penalties under PAMA and create unnecessary compliance risk.
New PAMA Applicability: What Hospital Outreach Laboratories Need to Know
The most significant change in the current PAMA reporting cycle is the expanded applicability for hospital outreach laboratories. Under the revised statutory definition of an applicable laboratory, many hospital outreach labs that were previously exempt from PAMA reporting are now required to report private payer payment data to CMS.
Hospital and health system leaders should not assume their organization's prior reporting status still applies. If your laboratory performs outreach testing for non-hospital patients, now is the time to determine whether your organization meets the updated applicability criteria and is required to report.
What Data Must Laboratories Report Under PAMA?
For the current clinical laboratory reporting cycle, applicable laboratories must report the HCPCS code, the final private payer allowed amount (including both the insurer payment and any patient cost sharing), the associated test volume, and the laboratory's National Provider Identifier (NPI). Reportable private payer data includes payments from commercial health insurance plans, Medicare Advantage plans, Medicaid Managed Care Organizations (MCOs), and group health plans. Under current CMS requirements, laboratories must report both in-network and out-of-network payment rates, as applicable.
CMS Resources to Help You Meet the July 31 Deadline
If you're still preparing your PAMA submission, CMS offers several resources to help laboratories navigate the reporting process and avoid common compliance issues. Whether you need to confirm your laboratory's reporting status, prepare your data file, or complete your submission through the CMS Enterprise Portal, these materials can help streamline the process before the July 31deadline.
-
CLFS & PAMA Reporting and Resources webpage – The central hub for reporting requirements, deadlines, training materials, templates, and system updates.
-
PAMA FAQs – Answers to common questions about applicable laboratories, reporting entities, reportable data, and penalties.
-
CLFS Events and Webinars – Access recordings, presentation slides, and Q&A materials from CMS PAMA reporting webinars, along with announcements and educational resources related to the current reporting cycle.
-
Quadax On-Demand Webinar: What New PAMA Requirements Mean for Labs – Hear ACLA President Susan Van Meter and ACLA General Counsel Joyce Gresko explain the latest PAMA legislation, updated reporting requirements, and key steps laboratories should take to prepare for upcoming reporting cycles.
Taking advantage of these resources can help reduce reporting errors, support compliance, and ensure your organization is prepared to meet the reporting deadline.
Why Does Accurate PAMA Reporting Matter for Laboratories?
Although additional Medicare payment reductions under the CLFS are currently delayed, the data submitted during this PAMA reporting cycle will play a critical role in shaping future Medicare reimbursement rates. CMS uses private payer payment data reported by applicable laboratories to calculate market-based rates for laboratory services, meaning the accuracy and completeness of every submission can impact reimbursement across the entire laboratory industry.
As more labs participate in PAMA reporting, the data pool used to establish future CLFS rates becomes more representative of the current laboratory market. Accurate reporting helps ensure that Medicare payment rates reflect real-world payment conditions and reduces the risk that incomplete or inaccurate data could influence future reimbursement decisions.
For individual laboratories, accurate reporting is also essential for maintaining compliance and avoiding unnecessary administrative challenges. Organizations should take time to validate payer contracts, confirm payment data, review reporting files, and ensure all required information is complete before submitting through the CMS Enterprise Portal.
Preparing early can help identify potential data gaps, address reporting questions, and avoid last-minute issues as the deadline approaches. A thorough and accurate submission not only supports compliance—it helps contribute to a more reliable foundation for future Medicare laboratory reimbursement.
Final Steps for Meeting the PAMA Reporting Deadline
While industry organizations such as the American Clinical Laboratory Association (ACLA) and the College of American Pathologists (CAP) continue to advocate for long-term PAMA reform, today's priority is ensuring successful completion of the current PAMA reporting requirements. Taking time to prepare now can help laboratories reduce compliance risks, avoid last-minute challenges, and submit accurate data through the CMS Enterprise Portal before the July 31 deadline.
To ensure accurate reporting, labs should:
- Validate private payer payment data for the January 1— June 30, 2025 reporting period.
- Confirm HCPCS codes and corresponding test volumes are complete and accurate.
- Review National Provider Identifier (NPI) information for accuracy.
- Assign the required Submitter and Certifier roles in the CMS Enterprise Portal.
- Conduct a final audit to identify and correct any discrepancies before submission.
- Submit your PAMA reporting data before the July 31, 2026 deadline to avoid last-minute issues.
By taking action now and submitting accurate, complete data, laboratories can reduce compliance risk while helping shape a more representative Medicare reimbursement landscape. The deadline is more than a reporting milestone—it is a critical opportunity for laboratories to influence future reimbursement decisions and ensure they are positioned for PAMA-driven changes ahead.
